Welcome to 3TR

Pathobiology-Driven Precision Therapy in RA
(3TR Precis-The-RA) study

3TR consortium

3TR Precis The RA is part of 3TR (Taxonomy, Treatment, Target and Remission) consortium project. The overall aim of the 3TR Project is to provide fundamental new insights into the mechanisms of response and non response to treatment across seven disease areas, one of which is Rheumatoid arthritis (RA).

For further information about the 3TR consortium, please visit their website.


Number of recruits:   
Number of sites open:   

The new 3TR Trials - The promise of personalised medicine for Rheumatoid Arthritis

Monday 20th March 2023 2-3.30pm (UK time)

Invitation to a talk by Professor Pitzalis

Please join us for an online talk by Costantino Pitzalis (Professor of Rheumatology at Queen Mary University of London) about the research taking place at the Centre for Experimental Medicine and Rheumatology (EMR). An leaflet about the event can be found here and a link to Eventbrite page where you can register to attend can be found here.